Goldstein, L. B., Amarenco, P., Bogousslavsky, J., Callahan, A. S., Hennerici, M. G., Welch, K. M. A., … Sillesen, H. (2004). Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. Cerebrovasc Dis, 18(1), 1–2. https://doi.org/10.1159/000078600

Goldstein, Larry B., Pierre Amarenco, Julien Bogousslavsky, Alfred S. Callahan, Michael G. Hennerici, K Michael A. Welch, Justin Zivin, and Henrik Sillesen. “Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out.” Cerebrovasc Dis 18, no. 1 (2004): 1–2. https://doi.org/10.1159/000078600.

Goldstein LB, Amarenco P, Bogousslavsky J, Callahan AS, Hennerici MG, Welch KMA, et al. Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. Cerebrovasc Dis. 2004;18(1):1–2.

Goldstein, Larry B., et al. “Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out.” Cerebrovasc Dis, vol. 18, no. 1, 2004, pp. 1–2. Pubmed, doi:10.1159/000078600.

Goldstein LB, Amarenco P, Bogousslavsky J, Callahan AS, Hennerici MG, Welch KMA, Zivin J, Sillesen H. Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. Cerebrovasc Dis. 2004;18(1):1–2.